- ►diabetesjournals.org KH Kahler, M Rajan, GG Rhoads, MM Safford, … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— A retrospective cohort study using data obtained
from the VHA Diabetes Epidemiology Cohort was used. Users of oral
antihyperglycemic therapy were classified into the following cohorts: ... Cited by 15 - Related articles - BL Direct - All 5 versions
KHKR Ph, PD SM, N Pharmaceuticals - Am Diabetes Assoc Page 1. 1 Impact of oral anti-hyperglycemic therapy on all-cause mortality among
patients with diabetes in the Veterans Health Administration ... Related articles - All 2 versions
[CITATION] Sulphonylureas and cardiovascular risk: facts and controversies
B Costa, JM Hernández - Medicina clínica, 1993 - ncbi.nlm.nih.gov BACKGROUND: To analyze the evolution of the use of drugs in diabetes, the
consumption of hypoglycemic medication in the province of Tarragona, the
autonomic community of Catalonia and Spain as a whole, was studied. A ... Cited by 2 - Related articles
[CITATION] PPARα and human metabolic disease
RK Semple, VKK Chatterjee, SO'Rahilly - Journal of Clinical Investigation, 2006 Cited by 2 - Related articles
[CITATION] GALLANT 9 Study Group. Efficacy, safety and tolerability of tesaglitazar when added to the …
J Belsey, G Krishnarajah - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 3 - Related articles - All 3 versions
- ►nih.gov - Free from Publisher AD Rao, N Kuhadiya, K Reynolds, VA … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A MEDLINE search (January 1966–July 2007) was
conducted to identify observational studies that examined the association
between combination therapy of sulfonylureas and metformin on risk of CVD ... Cited by 14 - Related articles - BL Direct - All 9 versions
JM Evans, SA Ogston, F Reimann, FM Gribble … - Diabetes Obesity and Metabolism, 2008 - interscience.wiley.com To assess whether users of pancreatic-specific sulphonylureas are at reduced
risk of mortality and cardiovascular mortality compared with users of
non-specific sulphonylureas, we conducted a cohort study in the population ... Cited by 4 - Related articles - BL Direct - All 3 versions
